Erschienen in:
18.09.2020 | ASO Author Reflections
ASO Author Reflections: Re-Excision for Ductal Carcinoma In Situ: Who Is at Risk?
verfasst von:
Leslie R. Lamb, MD, MSc, Manisha Bahl, MD, MPH
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 3/2021
Einloggen, um Zugang zu erhalten
Excerpt
For women with ductal carcinoma in situ (DCIS), successful breast-conserving surgery (BCS) requires tumor-negative surgical margins to decrease the risk of local recurrence.
1 If necessary, one or more re-excisions can be performed to achieve negative margins, but these additional surgeries after BCS result in adjuvant treatment delays and undesirable cosmesis, in addition to financial and psychological consequences.
2 In the past, research on re-excision and associated risk factors has tended to focus less on DCIS, as compared to invasive cancer, and often has combined patients with DCIS and those with invasive cancer despite higher re-excision rates for DCIS and evolving guidelines for appropriate margin width.
3 …